| Name | Title | Contact Details |
|---|
Build Your Proactive Myopia Management Practice With Euclid Orthokeratology!Euclid Systems Corporation is a global leader in Advanced Orthokeratology and Proactive Myopia Management. Proven on millions of eyes around the world, Euclid Ortho-K lenses are designed for the individual patient`s eyes. Thanks to the power of Three Factor Fitting, integrating Euclid orthokeratology into your practice is easy! Simply provide three parameters: RX, K Readings, and HVID. This efficient, empirical process yields a category-leading 87%* first fit success. No trial lenses required. With headquarters in, Virginia, USA, Euclid manufactures all products exclusively in the United States with approval from the U.S. Food & Drug Administration (FDA). The company additionally has offices in Shanghai and Beijing, China, and is leading global efforts in myopia management in children.
SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE`s portfolio of products and product candidates activate biologic signaling and angiogenic reponses, including revascularization and microcirculation, helping to restore the body`s normal healing processes and regeneration. These devices, based on Pulsed Acoustic Cellular Expression (PACE™) technology, are being developed and commercialized for use in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.
Medica Corporation is a Bedford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
DXE Medical is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Trice Medical was founded to fundamentally improve orthopedic diagnostics. Trice has pioneered fully integrated camera-enabled technologies that provide a clinical solution that is optimized for the physicians office. Our mission is to provide more immediate and definitive patient care, eliminating the false reads associated with current indirect modalities and significantly reduce the overall cost to the healthcare system.